-

SHAREHOLDER ALERT: Robbins LLP Reminds Shareholders of Class Action Against Gatos Silver, Inc. (GATO)

SAN DIEGO--(BUSINESS WIRE)--The Class: Shareholder rights law firm Robbins LLP informs investors that a shareholder filed a class action on behalf of persons and entities that purchased or otherwise acquired Gatos Silver, Inc. (NYSE: GATO) (a) common stock pursuant to the Company's October 2020 initial public offering ("IPO") and/or (b) securities between October 28, 2020 and January 25, 2022. Gatos Silver engages in the exploration, development, and production of precious metals.

If you would like more information about our investigation of Gatos Silver, Inc.'s misconduct, click here.

What is this Case About: Gatos Silver, Inc. (GATO) Announces Errors in Mineral Resource and Reserve Estimates in its 2020 Technical Report

According to the complaint, defendants made false and misleading statements in the Registration Statement in support of the IPO and during the class period. Specifically, defendants failed to disclose to investors: (1) that the technical report for Gatos Silver's primary mine contained certain errors, and (2) the mineral reserves had been overstated by as much as 50%.

On January 25, 2022, Gatos Silver provided a resource and reserve update for the Los Gatos Joint Venture, concluding "that there were errors in the technical report entitled 'Los Gatos Project, Chihuahua, Mexico' with an effective date of July 1, 2020 (the ‘2020 Technical Report'), as well as indications that there is an overestimation in the existing resource model." Therefore, "[o]n a preliminary basis, the Company estimates a potential reduction of the metal content of CLG's mineral reserve ranging from 30% to 50% of the metal content remaining after depletion" and advised that "the mineral resource and reserve estimates in the 2020 Technical Report should not be relied upon." Following this news, Gatos Silver stock fell by 69% to close at $3.17 per share on January 26, 2022. By the commencement of the lawsuit, Gatos Silver shares were still down significantly from its $7.00 per share IPO price.

Next Steps: If you acquired shares of Gatos Silver, Inc. (GATO) pursuant to the Company's October 2020 IPO or between October 28, 2020 and January 25, 2022, you have until April 25, 2022, to ask the court to appoint you lead plaintiff for the class. A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation. You do not have to participate in the case to be eligible for a recovery.

All representation is on a contingency fee basis. Shareholders pay no fees or expenses.

Contact us to learn more:

Aaron Dumas
(800) 350-6003
adumas@robbinsllp.com
Shareholder Information Form

About Robbins LLP: A recognized leader in shareholder rights litigation, the attorneys and staff of Robbins LLP have been dedicated to helping shareholders recover losses, improve corporate governance structures, and hold company executives accountable for their wrongdoing since 2002. To be notified if a class action against Gatos Silver, Inc. settles or to receive free alerts when corporate executives engage in wrongdoing, sign up for Stock Watch today.

Attorney Advertising. Past results do not guarantee a similar outcome.

Contacts

Aaron Dumas
Robbins LLP
5040 Shoreham Place
San Diego, CA 92122
adumas@robbinsllp.com
(800) 350-6003
www.robbinsllp.com

Robbins LLP

NYSE:GATO

Release Summary
Gatos Silver, Inc. (GATO) Announces Errors in Mineral Resource and Reserve Estimates in its 2020 Technical Report
Release Versions
$Cashtags

Contacts

Aaron Dumas
Robbins LLP
5040 Shoreham Place
San Diego, CA 92122
adumas@robbinsllp.com
(800) 350-6003
www.robbinsllp.com

More News From Robbins LLP

Investor Notice: Robbins LLP Informs Investors of the Regencell Bioscience Holdings Limited Class Action

SAN DIEGO--(BUSINESS WIRE)--Robbins LLP informs stockholders that a class action was filed on behalf of all investors who purchased or otherwise acquired Regencell Bioscience Holdings Limited (NASDAQ: RGC) securities between October 28, 2024 and October 31, 2025. Regencell is a purported early-stage bioscience company focused on the research, development, and commercialization of traditional Chinese medicine (“TCM”) for the treatment of attention-deficit/hyperactivity disorder (“ADHD”) and autis...

Investor Notice: Robbins LLP Informs Investors of the Globant S.A. Class Action

SAN DIEGO--(BUSINESS WIRE)--Robbins LLP informs stockholders that a class action was filed on behalf of all investors who purchased or otherwise acquired Globant S.A. (NYSE: GLOB) common stock between February 15, 2024 and August 14, 2025. Globant is a Luxembourg-incorporated international technology company that provides digital consulting and related services. For more information, submit a form, email attorney Aaron Dumas, Jr., or give us a call at (800) 350-6003. The Allegations: Robbins LL...

Investor Notice: Robbins LLP Informs Investors of the zSpace, Inc. Class Action

SAN DIEGO--(BUSINESS WIRE)--Robbins LLP informs stockholders that a class action was filed on behalf of all investors who purchased or otherwise acquired zSpace, Inc. (NASDAQ: ZSPC) securities pursuant and/or traceable to the Registration Statement and Prospectus issued in connection with the Company's December 2024 initial public statement ("IPO"). zSpace purports to be a leading provider of augmented reality (AR) and virtual reality (VR) educational technology solutions.For more information, s...
Back to Newsroom